Hydrocortisone 50 mg at 6-or 8-hour intervals was given after operation with the aim of keeping the total hydrocortisone dose during the day of operation at 200 to 300 mg.
Case 1: Cushing's syndrome with virilization and right hemihypertrophy. Body asymmetry had been noted at 6 months of age. At 3 years she underwent a laparotomy elsewhere because she was thought to have a gonadal tumour. Postoperatively, she developed wound infection and delayed wound healing.
After admission to this hospital, additional investigations were carried out. These included a dexamethasone test which showed no suppression of her urinary 17-ketosteroids (17KS) and 17-hydroxycorticoids (170HCS). Her cortisol production rate was 57*4 mg/m2 per 24 hours. A right adrenalectomy was performed. Because of the fear of recurrence of delayed wound healing, the hydrocortisone dose was reduced rapidly to 100, 75, and 50 mg on successive postoperative days. On the fourth day, she underwent an Addisonian crisis but responded to appropriate therapy. Case 5: Cushing's syndrome due to multiple bilateral adrenocortical adenomata. The left adrenal gland was removed. The gland weighed 2 *5 g. Histologically, multiple cortical adenomata were found. Postoperatively, the urinary 17-hydroxycorticoids remained raised, the levels ranging from 11 to 14 mg/24 hours. Two months later, a right adrenalectomy was performed. This adrenal gland weighed 3-5 g, showed multiple cortical adenomata histologically, and its medulla was completely destroyed. The patient was subsequently followed at 6-month intervals.
She developed convulsions 31 years after operation and died soon afterwards. At necropsy, voluminous lungs were found from which an adenovirus was cultured. There were no abnormal findings elsewhere.
Case 6: Cushing's syndrome with virilization, mistaken for congenital adrenal hyperplasia. This patient developed pubic hair at 10 months. At 2j years of age, she was thought to have congenital adrenal hyperplasia and was treated elsewhere with cortisone. Her urinary 17KS and 170HCS were 5 0 and 4 8 mg/24 hours. Neither pregnanetriol nor the 1 1-oxygenation index were measured.
She was referred because of progressive and uncontrolled virilization and the recent additional onset of cushingoid features. Preoperative diagnostic tests were carried out. At operation, a large adrenal tumour was found wrapped around the kidney which had to be removed with the tumour. Postoperatively, her hydrocortisone dose was reduced cautiously to 30 mg/ day (divided doses) by the end of the fifth week, and to 15 and 10 mg/day at 3 and 6 months. To date, no postoperative complications have been found. Case 7: Cushing's syndrome with virilization.
At operation, the right adrenal gland with the tumour was removed. The left adrenal gland was noted to be very small. Postoperatively, the hydrocortisone dose was reduced cautiously and was stopped completely by the end of the eighth week. At this time, urinary 17KS and 170HCS were 0*2 and 1*4 mg/24 hours. After an ACTH stimulation test, urinary 170HCS rose only to 2*3 mg/24 hours. Hydrocortisone therapy was not reinstituted. He has been followed for 9 years, and there have been no complications.
Case 8. Cushing's syndrome. After operation the hydrocortisone dose was reduced cautiously and was stopped after 3 months. He has remained well during the subsequent 3 years.
Discussion
All 8 patients showed significant hypertension, and it could be postulated that their lesions produced both cortisol and salt-retaining hormones.
In addition, 5 patients had pubic hair and other virilizing features and their tumours probably also produced androgens. Males and females were equally affected. All patients were overweight (for height), the weight exceeding the 90 to 97 centile in all cases except one. Only 3 patients were below the 3rd centile in height. In 3 additional patients (who also were virilized), the heights were on the 75th and 50th centiles. A unilateral tumour was found in 6 cases, 3 of which had virilizing features. One case had bilateral adrenocortical hyperplasia; another had multiple bilateral adrenocortical adenomata, and both presented with virilizing and cushingoid features.
In the diagnostic tests performed before operation (Raiti, 1971) , all patients had raised urinary 17KS and 170HCS. DHA was found in the urine of the 4 cases so studied and was very high in 2. The IVP showed a displaced kidney on the affected side in 5 of the 7 cases so studied, and all 5 had a unilateral tumour. The 6th and 7th cases had bilateral adrenal hyperplasia and bilateral tumours. Air insufflation was, therefore, rarely required. The dexamethasone suppression test (Wilkins, 1965) showed no alteration of the urinary 170HCS excretion in the 2 patients so studied. This test has been used to differentiate adrenal tumours from bilateral hyperplasia and from simple obesity, but is not needed if a unilateral lesion can be shown by IVP. Moreover, this test does not always differentiate benign from malignant lesions (with or without metastases). Such metastases are recognized either at operation, or by radiological or other changes in other organs, or by showing histological infiltration of the tumour capsule, or by finding a rising urinary steroid excretion pattern postoperatively. The histological features of benign and malignant tumours are often very similar.
Postoperatively, 2 patients developed impending adrenal crises which were thought to be due to rapid reduction in hydrocortisone dose in patients whose tissues had become adjusted to high levels. These patients responded to therapy which included increased hydrocortisone dosage. The one patient (Case 3) with the highest preoperative blood pressure, developed both severer hypertension and electrolyte changes which were suggestive of excess salt-retaining hormone. It is possible that her tumour was secreting both cortisol and salt-retaining hormones. One patient (Case 4) was given DOCA after operation and he developed severe hypertension. Unless there are specific indications, it is not necessary to give prophylactic salt-retaining hormones routinely in addition to hydrocortisone to patients who have a unilateral adrenalectomy, because the secretion of aldosterone is controlled by the renin-angiotension mechanism from the kidney rather than by pituitary ACTH (Raiti et al., 1966 (Raiti et al., , 1968 . Delayed or disordered wound healing was not a feature of our patients. One patient developed acute pancreatitis and died. Another died from an unrelated pneumonia 31 years after operation.
A small contralateral adrenal gland was seen in the 2 cases where this was looked for at operation, and one of these showed no response to ACTH stimulation 2 months later. Suppression of pituitary ACTH secretion is expected in patients with cortisol-secreting adrenal tumours, and this should result in a small contralateral gland. Such expected low plasma levels of ACTH and also of cortisol have been shown during the first few postoperative months, and complete recovery of both parameters only occurred after 9 months (Graber et al., 1965) . In addition, the clinical features of adrenal insufficiency may resemble those found with the steroid withdrawal syndrome, which includes anorexia, nausea, lethargy, weight loss, and arthralgia. These symptoms may be due to conditioning of the body tissues to high levels of adrenal corticosteroids (Amatruda, Hurst, and D'Esopo, 1965) .
In anticipation of such problems, patients should be given hydrocortisone in doses of 200 mg/day for 2 days and also 100 mg 2 hours before surgery. Postoperatively, the patients should receive 50 mg hydrocortisone every 6 hours for 3 days. These dose schedules appear to be adequate for most cases and overcome the dangers resulting either from higher dose levels or from too rapid withdrawal of hydrocortisone. Salt-retaining hormones need not be given unless specifically indicated. The total daily hydrocortisone dose should be reduced at 4-day intervals to 150, 100, 75, 50, and 30 mg. The patients can be discharged by the end of the third week on doses (divided) of 30 or 22 5 mg hydrocortisone per day. This dose is further reduced at 3 and 6 months, and discontinued after 9 months.
Associated disorders include osteoporosis which was noted in 3 of our cases, one of which also had virilizing features. Such oesteoporosis usually affects the lower thoracic and lumbar vertebrae and was reported in 83% of cases (Plotz, Knowlton, and Ragan, 1952) . It may persist for some months or years and no specific therapy is required (Soffer, Iannaccone, and Gabrilove, 1961) . One of our affected patients has been followed for one year and has shown no complications. Hemihypertrophy was found in one of our patients, and this association has been reported previously (Gellis and Feingold, 1966; Copple and Duncan, 1966; Fraumeni and Miller, 1967) . Another patient had renal calculi. Other disorders associated with adrenal tumours but not found in our patients have included congenital renal tract abnormalities, hamartomas, astrocytomas, congenital brain agenesis (Fraumeni and Miller, 1967) , neuroblastoma (Kenny et al., 1967) , renal ganglioneuroblastoma (Kogut and Donnell, 1961) , nephrocalcinosis, duodenal ulcer, generalized oesteoporosis (Perlmutter et al., 1962) , and mental deficiency (Sobel and Taft, 1959) .
It is therefore recommended that special attention be given to the pre-and postoperative medical management of patients with adrenal tumours that secrete cortisol. Fewer such difficulties have been experienced with patients who have androgen secreting tumours of the adrenal gland and who present with virilizing but no cushingoid features.
